CRB Monitor Securities Database Updates
During the week of December 2 - 8, 2024, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of December 2 - 8, 2024:
|
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
|
Tier 1A |
146 |
121 / 23 / 2 |
+0 | -0 | +0 |
|
Tier 1B |
703 |
552 / 149 / 2 |
+0 | -0 | +0 |
|
Tier 2 |
301 |
282 / 14 / 5 |
+0 | -1 | -1 |
|
Tier 3 |
465 |
437 / 27 / 1 |
+1 | -0 | +1 |
|
Total Issuances |
1,615 |
1,392 / 213 / 10 |
+1 | -1 | +0 |
|
Total Issuers (w/o Pre-IPOs) |
1,209 |
- |
+1 | -1 | +0 |
|
Total Issuers (w/ Pre-IPOs) |
1,219 |
- |
+1 | -1 | +0 |
Removed 1 Tier 2 Security:
- -1 = Discarded Business Record: ("Phoenix Life Sciences International Limited")
- Rationale = Phoenix Life Sciences International Limited, based in Australia, is an adaptive healthcare solutions company. The company is primarily focused on diabetes management solutions. The company was previously involved in the cannabis industry through the research and development of various cannabinoid-based pharmaceutical products. However, the company's security has been revoked/delisted and it no longer trades (previously traded on OTC only). As a result, the company is now private. This is a business without any connection to (1) a cannabis license/"plant-touching" operation, (2) a Tier 1 CRB, and/or (3) a publicly-traded CRB. Therefore, this business no longer qualifies for inclusion.
Added 1 Tier 3 Security:
- +1 = New CRB: ("Institute of Biomedical Research Corp.")
All newly-identified CRBs during the week:
|
Company Name |
Tier |
Pure-Play | Sector |
Description |
| 3 | No | CBD - Pharma & Biotech |
Institute of Biomedical Research Corp. (OTC Pink: MRES), operating as M2Bio Sciences, is a biotechnology company focused on alternative plant-based food, medicine and mental health therapeutic research. |